Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.
Takuya Suzuki, Takao Takase, Takafumi Koyama, Jun Sato, Toshio Shimizu, Hanae Ida, Makoto Nishino, Yoshiaki Nakamura, Shu Yazaki, Yuki Katsuya, Satoru Iwasa, Kazuki Sudo, Shunsuke Kondo, Kan Yonemori, Kohei Shitara, Satoshi Shiono, Daiko Matsuoka, Keisuke Yasuda, Yohei Otake, Shuya Takashima, Kohei Yamaguchi, Taro Semba, Noboru Yamamoto
Cancer research communications 2023;3(7):1189-1199